Close
Close

Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease

Access Programs

Disease Information

Descriptive Information
Brief Title † Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Official Title † Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols
Brief Summary This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.
Detailed Description Background: - Patients enrolled on CCR clinical protocols may require long term follow-up to assess outcome (e.g., survival) or the effects of prior therapy. - Keeping the primary treatment protocols open after accrual is complete in order to follow patients for long term outcome is an administrative burden on investigators and the IRB. Objectives: -To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol. Eligibility: -Patients who were previously enrolled on a CCR protocol and who are not eligible for an active NCI intramural primary research protocol. Design: - The medical procedures/tests will be based on the patient's diagnosis, treatment and supporting clinical information. This is a follow-up study in which only standard tests and procedures are to be performed. - Clinical information that is relevant to the patients prior protocols will be collected for research purposes. - Procedures that entail more than minimal risk to the patient should not be performed for research purposes on this protocol.
Study Phase N/A
Study Type † Observational
Study Design †
Primary Outcome Measure † To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol
Secondary Outcome Measure †
Condition † Melanoma Ovarian Cancer Prostate Cancer Breast Cancer Lymphoma
Intervention †
Study Arms / Comparison Groups
Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status †
Estimated Enrollment † 981
Start Date † May 1, 1996
Completion Date
Primary Completion Date
Eligibility Criteria † - ELIGIBILITY CRITERIA: Patients of any age who were previously enrolled on a CCR protocol. Not eligible for or unwilling to participate in an active NCI intramural primary research protocol. CCR investigator decides it is in the best interests of the patient and the CC for the patient to be seen in follow-up visits at the NIH. Patient or guardian is able to provide informed consent.
Gender All
Ages 7 Years - 100 Years
Accepts Healthy Volunteers No
Contacts ††
Location Countries † United States
Administrative Information
NCT ID † NCT00001503
Organization ID 960071
Secondary IDs †† 96-C-0071
Responsible Party Sponsor
Study Sponsor † National Cancer Institute (NCI)
Collaborators ††
Investigators † Principal Investigator: Caryn Steakley, R.N., National Cancer Institute (NCI)
Information Provided By
Verification Date November 9, 2016
First Received Date † November 3, 1999
Last Updated Date April 21, 2017
† Required WHO trial registration data element.
†† WHO trial registration data element that is required only if it exists.
Find a Clinical Trial
Related Videos
by Abidemi Uruejoma
752 views
Free Newsletter